key: cord-0967335-7vdv6w00
authors: Posio, C.; Ingegnoli, F.; Buoli, M.; Di Taranto, R.; Cumbo, E.; Lo Muscio, A.; Ostuzzi, S.; Caporali, R.
title: P.0493 COVID-19 related perceived stress in patients with rheumatic diseases: an Italian cross-sectional study
date: 2021-12-30
journal: Eur Neuropsychopharmacol
DOI: 10.1016/j.euroneuro.2021.10.465
sha: d58cd0c2d77d52dcf31073bd21f42e4ff48f2cb1
doc_id: 967335
cord_uid: 7vdv6w00

nan

Background: COVID-19 outbreak is a public emergency that forced people to a radical change in their daily life, generating great insecurities and concerns about health, work, and social relationships [1] . Quarantine measures were responsible for detrimental effects on mental health of the general population, leading to the exacerbation of stress, depression and anxiety [2] . Psychological impact might be even more severe on fragile people such as those suffering from rheumatic diseases (RDs), for whom previous evidence demonstrated a negative effect of psychological stressors on outcome disease [3] . Objective: The aim of the present study is to identify the factors associated with higher levels of perceived stress in patients affected by RDs during the COVID-19 pandemic. Methods: This cross-sectional study analyzed data from an anonymous online survey about mental health of people with RDs. Participants were enrolled through several RD patients' associations between May and September 2020, after the first pandemic wave in Italy. They filled out a questionnaire including demographic and clinical information, mental health issues and the Perceived Stress Scale (PSS). Perceived stress levels were stratified as follows: low ( < 14), moderate (14-26) and high ( > 27). Descriptive analyses were performed on the total sample; one-way analyses of variance (ANOVA) and Pearson's correlation were used to compare PSS scores between groups defined by qualitative and quantitative variables. Finally, multivariate regression analyses were performed to identify independent variables associated with higher PSS scores. Results: 507 patients with RDs participated in the survey: 419 females (82.6%) and 88 males (17.4%) with a mean age of 53.06 years and mean disease duration of 13.74 years. As regard PSS scores, total sample mean (SD) was 18.1 ± 8.1. Specifically, 154 patients (30,4%) reported low, 264 (52.1%) moderate and 89 (17.6%) high levels of stress. PSS scores resulted significantly different with regard to: gender (F = 18.32, P < 0.01), residence in Lombardy (F = 14.90, P < 0.01), diagnostic group (F = 6.20, P < 0.01), hypertension (F = 4.06, P = 0.04), gastritis (F = 3.83, P = 0.05), bowel diseases (F = 9.74, P < 0.01), overweight/obesity (F = 5.96, P = 0.02), COVID-19 infection (F = 4.32, P = 0.01), depressive symptoms (F = 17.18, P < 0.01), anxiety symptoms (F = 19.79, P < 0.01), prescription of psychiatric therapy before COVID-19 (F = 30.90, P < 0.01), type of pre-existing psychiatric symptoms (F = 12.41, P < 0.01), use of psychiatric compounds before COVID-19 (F = 36.39, P < 0.01), type of psychiatric compounds before COVID-19 (F = 13.53, P < 0.01), current prescription of psychiatric compounds (F = 44.68, P < 0.01), type of ongoing psychiatric compounds (F = 15.18, P < 0.01), anxiety sources (F = 30.90, P < 0.01). Independent variables associated with higher PSS scores were: female gender ( β= 0.12, P < 0.01), younger age ( β= -0.23, P < 0.01), residence outside Lombardy ( β= -0.09, P = 0.03), presence of overweight/obesity ( β= 0.11, P = 0.01), current prescription of psychiatric compounds ( β= 0.26, P < 0.01) and financial difficulties ( β= 0.19, P < 0.01). Conclusion: Our findings highlight the considerable psychological impact derived from COVID-19 pandemic on people affected by RDs. In addition, different factors resulted to be predictive of significant levels of perceived stress in these patients. A multidisciplinary approach, including mental health support, should be considered in order to improve the psychological well-being of fragile patients during traumatic events such as pandemics. Background: Post-traumatic stress disorder (PTSD) is a psychiatric condition that may develop after exposure to a traumatic event [1] ; COVID-19 pandemic could be defined as a traumatic experience since it has resulted in either direct (e.g. the fear of contagion and the risk of death) or indirect aftermaths (e.g. psychological distress, depression and anxiety) [2] . Besides, it has been shown that PTSD, promoting inflammatory responses, might worsen the prognosis of patients affected by illnesses characterized by systemic inflammation such as rheumatic diseases (RDs) [3] . Objective: The aim of the present study is to verify the presence of PTSD symptoms and related factors in patients suffering from RDs during the COVID-19 pandemic. Methods: This cross-sectional study analyzed data from an anonymous online survey about mental health of people with RDs. Participants were enrolled through several RD patients' associations between May and September 2020, after the first pandemic wave in Italy. They filled out a questionnaire including demographic and clinical information, mental health issues and the 22-items of the Impact of Event Scale-Revised (IES-R). The total score ranges from 0 to 88; a score ≥ 33 defines patients at risk of PTSD. Descriptive analyses were performed on the total sample: one-way analyses of variance (ANOVAs) were used to compare IES-R scores between groups defined by qualitative variables; Pearson's correlations were performed to study the relation between rating scale scores and quantitative variables. Finally, multivariate regression analyses were performed to identify independent variables associated with IES-R scores.

Results: 507 patients with RDs participated in the survey: 419 females (82.6%) and 88 males (17.4%) with a mean age of 53.06 years and mean disease duration of 13.74 years. As regard IES-R scores, total sample mean (SD) was 29.7 ± 17.5; of note, 209 participants (41.2%) had scores ≥33. IES-R scores resulted to be significantly different according to: gender (F = 14.75, P < 0.01), residence in Lombardy (F = 8.22, P < 0.01), diagnostic group (F = 4.17, P = 0.02), prescription of psychiatric therapy before COVID-19 (F = 17.87, P < 0.01), type of pre-existing psychiatric symptoms (F = 7.59, P < 0.01), use of psychiatric compounds before COVID-19 (F = 27.17, P < 0.01), type of psychiatric compounds before COVID-19 (F = 14.58, P < 0.01), current prescription of psychiatric compounds (F = 29.30, P < 0.01), type of ongoing psychiatric compounds (F = 13.81, P < 0.01), anxiety source (F = 20.81, P < 0.01), and the presence of overweight/obesity (F = 7.60, P < 0.01), bowel diseases (F = 8.00, P < 0.01), depressive symptoms (F = 5.74, P = 0.02), anxiety symptoms (F = 26.81, P < 0.01). Independent variables associated with higher IES-R scores were: female gender ( β= 0.14, P < 0.01), living outside Lombardy ( β= -0.10, P = 0.02), intestinal diseases ( β= 0.10, P = 0.03), anxiety ( β= 0.19, P < 0.01) and health related concerns ( β= 0.13, P < 0.01). Conclusion: These findings point out high rate of severe self-reported distress among Italian RD patients in response to the pandemic. Given that psychological and emotional stressors strictly affect disease severity leading to poorer quality of life, our study sustains the necessity to implement support measures for fragile patients during traumatic events.

No conflict of interest

Immune fitness, and the psychosocial and health consequences of the COVID-19 pandemic lockdown in The Netherlands: methodology and design of the CLOFIT study

The use of single-item ratings versus traditional multiple-item questionnaires to assess mood and health

Development and validation of the Immune Status Questionnaire (ISQ)

Diagnostic and statistical manual of mental disorders

COVID-19 Pandemic in the Italian Population: Validation of a Post-Traumatic Stress Disorder Questionnaire and Prevalence